• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Nanotechnology Platform Shows Promise for Treating Pancreatic Cancer

  Iron-overload Disease Causes Bloom of Potentially Deadly Bacteria
  A porous silica nanoparticle is loaded with a pancreaticcancer drug combination that is delivered to and effectively shrinks a human cancer grown in the pancreas of a mouse.
Graphic: Dr. Huan Meng

Scientists at UCLA’s California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer.

The study describes successful experiments to combine two drugs within a specially designed mesoporous silica nanoparticle that looks like a glass bubble. The drugs work together to shrink human pancreas tumors in mice as successfully as the current standard treatment, but at one-twelfth the dosage. This lower dosage could reduce both the cost of treatment and the side effects that people suffer from the current method.

Pancreatic cancer is difficult to detect early, and symptoms do not usually appear until the disease is advanced. As a result, many people are not diagnosed until their tumors are beyond the effective limits of surgery, leaving chemotherapy as the only viable treatment option. The chemotherapy drug most oft en used for pancreas cancer is gemcitabine, but its impact is oft en limited.

Recent research has found that combining gemcitabine with another drug called paclitaxel can improve the overall treatment effect. In the current method, Abraxane, a nano complex containing paclitaxel, and gemcitabine are given separately. Though this works to a degree, the combined beneficial effect is not fully synchronized because the drugs may stay in the body for different lengths of time.

In mice that received the two drugs inside the nanoparticle, pancreas tumors shrank dramatically compared with those in mice that did not receive the combined drugs in the nanoparticle. Similar comparisons were made with mouse models, in which the human tumors were surgically implanted into the mice’s abdomens in order to more closely emulate the natural point of origin of pancreatic tumors and provide a better parallel to the tumors in humans. In these experiments, the tumors in the mice receiving silica nanoparticles shrank more than the comparative controls. Also, metastasis to nearby organs was eradicated in these mice.

“Instead of just a laboratory proof-of-principle study of any cancer, we specifically attacked pancreatic cancer with a custom-designed nanocarrier,” says Andre Nel, MD, distinguished professor of medicine and associate director for research of the California NanoSystems Institute. “In our platform, the drugs are truly synergistic because we have control over drug mixing, allowing us to incorporate optimal ratios in our particles, making the relevance of our models very high and our results very strong.”

“Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice,” ACS Nano, March 16, 2015


Previous
In Utero Exposure to Extreme Morning Sickness May Harm Offspring
Next
Blood-based Test for Diagnosing Alzheimer’s Disease


YOU ARE VIEWING

Summer 2015

Summer 2015
E-Brochure
Printable PDF
IN THIS ISSUE
  • United We Stand
  • Stories of Recovery from Traumatic Brain Injury
  • Brain Abnormalities Similar in People with Anorexia and Body Dysmorphic Disorder
  • Drug That Can Head Off Diabetes Is Rarely Used
  • Characteristic Patterns of Proteins Found in Brains of Retired NFL Players Who Suffered Concussions
  • Scientists Patent Method for Finding Microscopic Needle in a Haystack
  • Mental-training Exercises Help Mitigate Effects of “Chemo Brain”
  • In Utero Exposure to Extreme Morning Sickness May Harm Offspring
  • Nanotechnology Platform Shows Promise for Treating Pancreatic Cancer
  • Blood-based Test for Diagnosing Alzheimer’s Disease
  • Electroconvulsive Therapy Changes Key Areas of the Brain That Play Roles in Memory and Emotion
  • ADAPT Program: Tailored Care to Address Special Needs
  • On the Trail of a Gene Mutation
  • Safe Haven
  • Interior Life
  • Balancing Act
  • Awards/Honors
  • In Memoriam
  • Sky’s the Limit
  • Postcard from Kenya
  • A Home-grown Team Battles Melanoma
  • In His Own Words: Scott Lee, MD ’02
  • Taste for a Cure Celebrates 20th Anniversary
  • Great Minds Gala Supports Outstanding Young Researchers
  • UCLA Health Forms Partnership with Sound Body Sound Mind Foundation
  • New Mobile App Focuses on Tools for Foster Families
  • Dedicated to a Cure for Pancreatic Cancer
  • Turning Sorrow into Laughter
  • Memorial Golf Tournament Supports Cancer Research
  • David and Susan Wilstein Pledge Support for Rehabilitation Services
  • Chairs of Distinction
  • Gifts
  • Awards/Honors: HeartRhythm Honors UCLA Cardiologist
  • Out of Africa: An Interview with Dr. Matthew Waxman
  • A Place to Turn for Help
  • Healing Space
  • Out of Africa
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth